Piedmont Heart interventional cardiologists discuss the latest outlook for using renal denervation to treat hypertension at the Napa Valley Cardiology Conference in June 2018.  Dr. David Kandzari, just back from EuroPCR 2018 where he presented results from the SPYRAL HTN trial, talked about what has changed since an earlier trial of Medtronic’s Symplicity Renal Denervation System failed to meet its primary endpoint, and the current, more positive implications for patient care.